Skip to main content

Table 1 Estimated average cost by child vaccinated (USD, $), according to cost category

From: Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru

Cost category

Current scheme

Alternative scheme

% Difference

Logistical costs

5.80

2.33

–59.8%

Vaccination costs

60.86

98.66

 + 62.1%

Cost of treatment for adverse reactions

11,293.89

28.22

–99.8%

 Cost of treatment of common adverse reactions

37.75

28.22

–25.3%

 Cost of treatment of OPV-derived polio

11,256.14

–100.0%

Social cost of lost time

1,289.65

17.50

–98.6%

 Cost of time lost due to vaccination

9.31

8.22

–11.7%

 Cost of time lost due to treatment of common adverse reactions

12.37

9.28

–25.0%

 Cost of time lost due to OPV-derived polio

1,267.97

–100.0%

Total

116.27

126.42

 + 8.7%

  1. USD, $1 equal to S/ 3.374 Peruvian Soles (average accounting exchange rate reported on December 31, 2018 by the Peruvian Superintendence of Banks, Insurance and Private Pension Fund Administrators [Superintendencia de Banca, Seguros y AFP]) [36]. OPV, oral polio vaccine; USD, US dollar